CYP3A422 and CYP3A53 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome.

Valentin Yurievich SkryabinJohan FranckVolker Martin LauschkeMikhail Sergeevich ZastrozhinValery Valerievich ShipitsynEvgeny Alekseevich BryunDmitry Alekseevich Sychev

Published in: Nordic journal of psychiatry (2022)

These results suggest that genotyping for common CYP3A variants might have the potential to guide benzodiazepine withdrawal treatment.

Keyphrases

copy number
high throughput
genome wide
case report
alcohol consumption
climate change
smoking cessation